Cargando…
Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway
Pulmonary fibrosis (PF) is a chronic pulmonary interstitial disease, and its pathological process is closely related to fibroblast–myofibroblast differentiation. Danshensu (DSS) has been reported to exert an anti-fibrotic effect in heart and liver. However, it is unknown whether DSS has an equally a...
Autores principales: | Liu, Huaman, Zhang, Xinyue, Shao, Yumeng, Lin, Xuehong, Dong, Feng, Liu, Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806824/ https://www.ncbi.nlm.nih.gov/pubmed/34187349 http://dx.doi.org/10.1080/21655979.2021.1944020 |
Ejemplares similares
-
Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation
por: Liu, Peng, et al.
Publicado: (2020) -
Fenbendazole Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice via Suppression of Fibroblast-to-Myofibroblast Differentiation
por: Wang, Lan, et al.
Publicado: (2022) -
Correction to: Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation
por: Liu, Peng, et al.
Publicado: (2023) -
Interference with connective tissue growth factor attenuated fibroblast-to-myofibroblast transition and pulmonary fibrosis
por: Yang, Zhizhou, et al.
Publicado: (2022) -
Noncoding RNAs: Master Regulator of Fibroblast to Myofibroblast Transition in Fibrosis
por: Zhang, Huamin, et al.
Publicado: (2023)